Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.53 EUR | -2.32% | -5.24% | -3.44% |
May. 24 | Innate Pharma: five abstracts selected for ASCO | CF |
May. 14 | Transcript : Innate Pharma S.A., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.44% | 222M | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+0.04% | 12.16B | |
+25.12% | 12.21B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- IPH Stock
- News Innate Pharma
- Innate Pharma S A : Shares Jump After SVB Leerink Upgrades Rating to Outperform